$65.96
2.063.22%
al cierre: Aug 19, 5:00 PM EST
$65.96
N/A
After hour: 4:00 PM EST
Travere Therapeutics Inc
TVTXNASDAQ
Travere Therapeutics Earnings & Forecasts
Travere Therapeutics (TVTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Travere Therapeutics Guidance
Travere Therapeutics (TVTX) publicó su última previsión de enero 9, 2023 para fiscal year 2022. La compañía estimó ingresos en un rango de $212M - $212M para el período.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.23 | $-0.10 | $0.24 | $-0.17 |
| Actual | $-0.10 | $0.05 | $0.37 | $0.59 |
| Surprise | -143.5% | +150.0% | +54.2% | +447.1% |
| Revenue | ||||
| Estimate | $159.3M | $135.3M | $145.6M | $105.0M |
| Actual | $169.6M | $127.2M | $129.7M | $164.9M |
| Surprise | +6.44% | -6.01% | -10.9% | +57.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.41 | $0.98 | $0.56 | $0.80 |
| Revenue | ||||
| Consensus | $193.5M | $231.4M | — | — |